obesity glp-1 news today Weight loss with medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans: Cell Reports Medicine Researchers find GLP-1 medications safe

The risk appeared class-wide, suggesting a mechanism related to GLP-1 receptor activity itself rather than formulation-specific differences

This feature was partially attenuated with GLP1-SSM treatment in DSS + GLP-1-SSM group

* Correspondence: Alicja Skrobucha [email protected] Senior authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Is the effect similar? Ultimately, the data show promise of another strategy for people struggling with alcohol use disorder and even the use of other addictive substances

So, why does Ozempic cause diarrhea

Participants were randomized to receive 3 mg, 7 mg, or 14 mg of oral semaglutide or 100 mg of sitagliptin once daily